Literature DB >> 24041649

Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study.

Bernhard M Kaess1, Philimon Gona, Martin G Larson, Susan Cheng, Jayashree Aragam, Satish Kenchaiah, Emelia J Benjamin, Ramachandran S Vasan.   

Abstract

OBJECTIVE: To investigate secular trends in echocardiographically determined left ventricular mass (LVM). DESIGN, SETTING AND PARTICIPANTS: Longitudinal community-based cohort study in Framingham, Massachussetts. LVM was calculated from routine echocardiography in 4320 participants (52% women) of the Framingham offspring cohort at examination cycles 4 (1987-1991), 5 (1991-1995), 6 (1995-1998) and 8 (2005-2008), totalling 13 971 person-observations. MAIN OUTCOME MEASURES: Sex-specific trends in mean LVM (and its components, LV diastolic diameter (LVDD) and LV wall thickness (LVWT)), and LVM indexed to body surface area (BSA).
RESULTS: In men, age-adjusted LVM modestly increased from examination 4 to 8 (192 g to 198 g, p-trend=0.0005), whereas, in women it decreased from 147 g at examination 4 to 140 g at examination 8 (p-trend<0.0001). The trend for increasing LVM in men tracked with an increasing LVDD (p-trend=0.0002), whereas the decline in LVM in women was accompanied by a decrease in LVWT (p-trend<0.0001). Indexing LVM to BSA abolished the increasing trend in men (p-trend=0.49), whereas, the decreasing trend in women was maintained.
CONCLUSIONS: In our longitudinal analysis of a large community-based sample spanning two decades, we observed sex-related differences in trends in LVM, with a modest increase of LVM in men (likely attributable to increasing body size), but a decrease in women. Additional studies are warranted to elucidate the basis for these sex-related differences.

Entities:  

Mesh:

Year:  2013        PMID: 24041649      PMCID: PMC4139052          DOI: 10.1136/heartjnl-2013-304600

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study.

Authors:  D Levy; K M Anderson; D D Savage; W B Kannel; J C Christiansen; W P Castelli
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

2.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

3.  Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: comparison with postmortem mass measurements.

Authors:  J N Woythaler; S L Singer; O L Kwan; R S Meltzer; B Reubner; W Bommer; A DeMaria
Journal:  J Am Coll Cardiol       Date:  1983-08       Impact factor: 24.094

4.  Trends in obesity and abdominal obesity among adults in the United States from 1999-2008.

Authors:  E S Ford; C Li; G Zhao; J Tsai
Journal:  Int J Obes (Lond)       Date:  2010-09-07       Impact factor: 5.095

5.  M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study).

Authors:  J M Gardin; R McClelland; D Kitzman; J A Lima; W Bommer; H S Klopfenstein; N D Wong; V E Smith; J Gottdiener
Journal:  Am J Cardiol       Date:  2001-05-01       Impact factor: 2.778

6.  Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.

Authors:  Bertram Pitt; Nathaniel Reichek; Roland Willenbrock; Faiez Zannad; Robert A Phillips; Barbara Roniker; Jay Kleiman; Scott Krause; Daniel Burns; Gordon H Williams
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

7.  Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Authors:  Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan M Edelman; Kristian Wachtell
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

10.  Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study.

Authors:  Johan Sundström; Lisa Sullivan; Jacob Selhub; Emelia J Benjamin; Ralph B D'Agostino; Paul F Jacques; Irwin H Rosenberg; Daniel Levy; Peter W F Wilson; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2004-03       Impact factor: 29.983

View more
  3 in total

Review 1.  Databases and registers: useful tools for research, no studies.

Authors:  Rafael J Curbelo; Estíbaliz Loza; Maria Jesús García de Yébenes; Loreto Carmona
Journal:  Rheumatol Int       Date:  2014-02-08       Impact factor: 2.631

2.  Associations of Circulating Extracellular RNAs With Myocardial Remodeling and Heart Failure.

Authors:  Ravi V Shah; Jian Rong; Martin G Larson; Ashish Yeri; Olivia Ziegler; Kahraman Tanriverdi; Venkatesh Murthy; Xiaojun Liu; Chunyang Xiao; Alexander R Pico; Tianxiao Huan; Daniel Levy; Gregory D Lewis; Anthony Rosenzweig; Ramachandran S Vasan; Saumya Das; Jane E Freedman
Journal:  JAMA Cardiol       Date:  2018-09-01       Impact factor: 14.676

3.  Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Ravi V Shah; Venkatesh L Murthy; Siddique A Abbasi; John Eng; Colin Wu; Pamela Ouyang; Raymond Y Kwong; Allison Goldfine; David A Bluemke; Joao Lima; Michael Jerosch-Herold
Journal:  Eur J Prev Cardiol       Date:  2014-07-09       Impact factor: 7.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.